Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. - Wikidata - awgldk - TriplyDB

Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

http://www.wikidata.org/entity/Q37268694

about

Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion Agonist Medications for the Treatment of Cocaine Use Disorder Management of fibromyalgia syndrome: review of evidence.Behavioral effects of gamma-hydroxybutyrate in humans Sodium oxybate for the treatment of fibromyalgia.The use of sodium oxybate to treat narcolepsy.Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons A web-based study of gamma hydroxybutyrate (GHB): patterns, experiences, and functions of use.GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Preference for gamma-hydroxybutyrate (GHB) in current users.Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.Illicit substance use in pregnancy - a review.Management of fibromyalgia syndrome in 2016.Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia Reconsidering GHB: orphan drug or new model antidepressant?Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assault.Screening and confirmation methods for GHB determination in biological fluids.Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study.Synthesis and stability study of a new major metabolite of γ-hydroxybutyric acid Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses.Risk factors of γ-hydroxybutyrate overdosing.Barriers To Research Using Controlled Drugs Are Not Created Equal.Sodium oxybate to treat alcohol dependence: 20 years of clinical experience.Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.Substitution therapy for alcoholism: time for a reappraisal?Dried blood spot punches for confirmation of suspected γ-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure.Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans

P2860

Q24653625-FBF58874-072D-4757-976C-ADE4C82349D6 Q28087404-891FA7F6-D433-4558-B636-44819709FF2E Q33938302-7F938193-004D-478F-83B5-9D057AE56CF8 Q34026042-0B4A7A53-71B1-4A35-A85D-6E2D086DD70B Q34193082-20E7F844-0917-4EA2-93E1-D9E7CED07193 Q34272284-7A732A73-8227-4F2A-93A2-CB66E61B5CD1 Q34630587-29F56E3D-CA35-4B29-BBBD-07CA052157C5 Q34730168-0FCFD3AA-A6BD-4B39-BFBB-7D95036F932D Q35710620-CC73791A-38DB-4B09-BF7B-7C3A97E84B83 Q36025811-6A8E9CF9-72BB-4658-ABC2-B4AF5772A294 Q36072485-D9FD7F73-4FDD-4158-98D7-996AC0726DE0 Q36539839-4E7CDCA9-DA8F-4242-943F-EF2602BCE761 Q37033882-371450C7-7074-4D74-9748-5066E9348A85 Q37185873-B7873DF4-FF17-41D6-8A81-E8D994D70C1F Q37342832-7A00A1DC-F129-401A-9FEB-323FCC39AE47 Q37472845-031CFD79-831C-4D75-A5CF-A5831DBD1A23 Q37690358-06280945-1BD1-4C64-9A9E-AAB310458399 Q37934335-2AB90638-28C2-4EF1-9BF6-FE17EA1DF57A Q37940945-6CC35243-1E3A-40C5-AE7E-EA07D0C4B607 Q38185603-FE6A08BA-1359-495D-B9FD-F9AC8F767C90 Q39048315-65E509E0-8F13-40E6-A303-4B865DD88EB1 Q39456871-3A5A09BF-FC5C-427C-9687-2714CED0E306 Q39903404-B1BEB900-6708-4333-9CA7-A271384F873D Q41462770-C028D56D-DC9C-48D8-9A00-A9A1C606A2D5 Q42183368-EAE815B9-4273-4F7D-AC23-CABC410B01E8 Q43883628-BAC56730-59F0-43FB-A2BA-0160B3CC9BCA Q45029630-D2190CDB-94B7-4660-974F-84F8EE8FAACE Q45798267-7FF70541-E941-4A80-AB6C-0C0E971A128F Q47841359-AD907BA2-C22E-4398-B754-D209EC66CF37 Q48248695-4DDE6F5A-08D4-40A8-BEDA-A9C985E29365 Q49044992-AE8D0920-4AA5-41CA-B7B2-41BB1DD6557B Q57299896-CE4D268B-819B-4952-853A-9CD88B1B50CA

P2860

Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

http://www.wikidata.org/entity/Q37268694

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Illicit gamma-hydroxybutyrate ...... in characteristics and misuse.

@en

Illicit gamma-hydroxybutyrate

@nl

type

label

Illicit gamma-hydroxybutyrate ...... in characteristics and misuse.

@en

Illicit gamma-hydroxybutyrate

@nl

prefLabel

Illicit gamma-hydroxybutyrate ...... in characteristics and misuse.

@en

Illicit gamma-hydroxybutyrate

@nl

P1433

Q37268694-ADA7EFEE-0258-422E-8B72-FDCFA5D4627A

P1476

Q37268694-75BDB1E9-9AF6-4A7D-A734-8CE21A0D313E

P2093

Q37268694-22D6040E-AB70-4BB1-8071-FEAD1B82D915

Q37268694-50C795C1-6090-4B69-9CFD-8282AE208537

Q37268694-73485FE0-CC45-4DC1-AA7E-7A52A99E4303

Q37268694-F668FDA0-1AB9-442A-94F6-A2E4EA9D4FE3

P2860

Q37268694-0480F01E-EE03-42AD-9A7F-569EA95D245C

Q37268694-0C36AED1-681A-4A3B-9DE6-58E282822827

Q37268694-11AA8F01-81CE-45E7-9C94-19CBCAE357B8

Q37268694-15241E95-3183-4C37-B8A6-5375552D0243

Q37268694-1A5BB5B8-C37C-425C-8378-CC475B63D08F

Q37268694-1E3E4447-819F-405C-8432-140495C17AE6

Q37268694-1F4A4F12-68DD-4AF6-9445-C1B71C89ABF7

Q37268694-21A0DF95-2D89-4848-B265-008EEC3887E9

Q37268694-2244CAFA-5FCB-4974-B670-509A93281F62

Q37268694-23F3BC59-AABD-475E-9230-5BE9A64AFC0A

P304

Q37268694-EC2546E8-C329-49AB-AEB6-1FF6289CF985

P31

Q37268694-45B8DE0C-7539-4CF5-B8A9-8B77E9FA3BAD

P356

Q37268694-066582AB-4D1B-443D-B28F-19B0D38774C8

P433

Q37268694-B3A617D7-17BD-41F1-8FED-AD29A9806CAA

P478

Q37268694-3AEA3823-D39F-4180-949E-59ED9AD18478

P577

Q37268694-C24F6F86-49F3-4135-AE0B-71A4574BA30B

P5875

Q37268694-E55DF8B9-5C11-45BD-9B52-67481123EAE6

P698

Q37268694-C5CF04A8-8F78-4C75-89C9-3D416E123C52

P932

Q37268694-42C1B929-01AB-4020-8B51-89DCB8161431

P356

J.DRUGALCDEP.2009.04.012

P1433

Drug and Alcohol Dependence

P1476

Illicit gamma-hydroxybutyrate ...... in characteristics and misuse.

@en

P2093

Daniel Pardi

http://www.w3.org/2001/XMLSchema#string

Jane Gorsline

http://www.w3.org/2001/XMLSchema#string

Lawrence P Carter

http://www.w3.org/2001/XMLSchema#string

Roland R Griffiths

http://www.w3.org/2001/XMLSchema#string

P2860

Behavioral analyses of GHB: receptor mechanisms

Gamma-hydroxybutyrate and ethanol effects and interactions in humans

Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion

Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds

A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor

2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).

Adverse events, including death, associated with the use of 1,4-butanediol.

Gamma-hydroxybutyrate withdrawal syndrome.

2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report.

Acute poisoning from gamma-hydroxybutyrate in California.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2009.04.012

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26264072

http://www.w3.org/2001/XMLSchema#string

P698

19493637

http://www.w3.org/2001/XMLSchema#string

P932

2713368

http://www.w3.org/2001/XMLSchema#string